655 related articles for article (PubMed ID: 14635080)
21. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.
Ozyar E; Gurkaynak M; Yildiz F; Atahan IL
Radiother Oncol; 2004 Jul; 72(1):71-7. PubMed ID: 15236877
[TBL] [Abstract][Full Text] [Related]
22. Upfront window trial of topotecan in previously untreated children and adolescents with poor prognosis metastatic osteosarcoma: children's Cancer Group (CCG) 7943.
Seibel NL; Krailo M; Chen Z; Healey J; Breitfeld PP; Drachtman R; Greffe B; Nachman J; Nadel H; Sato JK; Meyers PA; Reaman GH
Cancer; 2007 Apr; 109(8):1646-53. PubMed ID: 17334983
[TBL] [Abstract][Full Text] [Related]
23. Advanced seminoma--treatment results and prognostic factors for survival after first-line, cisplatin-based chemotherapy and for patients with recurrent disease: a single-institution experience in 145 patients.
Gholam D; Fizazi K; Terrier-Lacombe MJ; Jan P; Culine S; Theodore C
Cancer; 2003 Aug; 98(4):745-52. PubMed ID: 12910518
[TBL] [Abstract][Full Text] [Related]
24. Survival after recurrence of Ewing tumors: the St Jude Children's Research Hospital experience, 1979-1999.
Rodriguez-Galindo C; Billups CA; Kun LE; Rao BN; Pratt CB; Merchant TE; Santana VM; Pappo AS
Cancer; 2002 Jan; 94(2):561-9. PubMed ID: 11900241
[TBL] [Abstract][Full Text] [Related]
25. Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma.
Harting MT; Blakely ML; Jaffe N; Cox CS; Hayes-Jordan A; Benjamin RS; Raymond AK; Andrassy RJ; Lally KP
J Pediatr Surg; 2006 Jan; 41(1):194-9. PubMed ID: 16410132
[TBL] [Abstract][Full Text] [Related]
26. Survival after recurrence of osteosarcoma: a 20-year experience at a single institution.
Crompton BD; Goldsby RE; Weinberg VK; Feren R; O'Donnell RJ; Ablin AR
Pediatr Blood Cancer; 2006 Sep; 47(3):255-9. PubMed ID: 16123980
[TBL] [Abstract][Full Text] [Related]
27. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
[TBL] [Abstract][Full Text] [Related]
28. [Neoadjuvant chemotherapy for osteosarcoma].
Guo W; Yang RL; Tang XD; Tang S; Li DS; Yang Y
Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1186-90. PubMed ID: 15387981
[TBL] [Abstract][Full Text] [Related]
29. [Prognostic factors for the local recurrence of osteosarcoma in extremities treated with combined therapy].
Zhang Q; Niu XH; Cai YB; Hao L; Ding Y
Zhonghua Wai Ke Za Zhi; 2007 Aug; 45(16):1114-7. PubMed ID: 18005614
[TBL] [Abstract][Full Text] [Related]
30. Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy.
Bacci G; Briccoli A; Longhi A; Ferrari S; Mercuri M; Faggioli F; Versari M; Picci P
Acta Oncol; 2005; 44(7):748-55. PubMed ID: 16227167
[TBL] [Abstract][Full Text] [Related]
31. Osteogenic sarcoma of the extremity with detectable lung metastases at presentation. Results of treatment of 23 patients with chemotherapy followed by simultaneous resection of primary and metastatic lesions.
Bacci G; Mercuri M; Briccoli A; Ferrari S; Bertoni F; Donati D; Monti C; Zanoni A; Forni C; Manfrini M
Cancer; 1997 Jan; 79(2):245-54. PubMed ID: 9010097
[TBL] [Abstract][Full Text] [Related]
32. Definitive surgery and multiagent systemic therapy for patients with localized Ewing sarcoma family of tumors: local outcome and prognostic factors.
Krasin MJ; Davidoff AM; Rodriguez-Galindo C; Billups CA; Fuller CE; Neel MD; Merchant TE
Cancer; 2005 Jul; 104(2):367-73. PubMed ID: 15948159
[TBL] [Abstract][Full Text] [Related]
33. Telangiectatic osteosarcoma of the extremity: neoadjuvant chemotherapy in 24 cases.
Bacci G; Ferrari S; Ruggieri P; Biagini R; Fabbri N; Campanacci L; Bacchini P; Longhi A; Forni C; Bertoni F
Acta Orthop Scand; 2001 Apr; 72(2):167-72. PubMed ID: 11372948
[TBL] [Abstract][Full Text] [Related]
34. Neoadjuvant chemotherapy for radioinduced osteosarcoma of the extremity: The Rizzoli experience in 20 cases.
Bacci G; Longhi A; Forni C; Fabbri N; Briccoli A; Barbieri E; Mercuri M; Balladelli A; Ferrari S; Picci P
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):505-11. PubMed ID: 17118571
[TBL] [Abstract][Full Text] [Related]
35. Primary osteogenic sarcoma with pulmonary metastasis: clinical results and prognostic factors in 91 patients.
Wu PK; Chen WM; Chen CF; Lee OK; Haung CK; Chen TH
Jpn J Clin Oncol; 2009 Aug; 39(8):514-22. PubMed ID: 19525290
[TBL] [Abstract][Full Text] [Related]
36. A phase II study of cisplatin, doxorubicin, and ifosfamide with peripheral blood stem cell support in patients with skeletal osteosarcoma and variant bone tumors with a poor prognosis.
Patel SR; Papadopolous N; Raymond AK; Donato M; Seong CM; Yasko AW; Lewis VO; Lin PP; Champlin R; Benjamin RS
Cancer; 2004 Jul; 101(1):156-63. PubMed ID: 15222001
[TBL] [Abstract][Full Text] [Related]
37. Telangiectatic osteosarcoma: the St. Jude Children's Research Hospital's experience.
Weiss A; Khoury JD; Hoffer FA; Wu J; Billups CA; Heck RK; Quintana J; Poe D; Rao BN; Daw NC
Cancer; 2007 Apr; 109(8):1627-37. PubMed ID: 17351949
[TBL] [Abstract][Full Text] [Related]
38. High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma.
Crews KR; Liu T; Rodriguez-Galindo C; Tan M; Meyer WH; Panetta JC; Link MP; Daw NC
Cancer; 2004 Apr; 100(8):1724-33. PubMed ID: 15073863
[TBL] [Abstract][Full Text] [Related]
39. Telangiectatic osteogenic sarcoma. Improved survival with combination chemotherapy.
Rosen G; Huvos AG; Marcove R; Nirenberg A
Clin Orthop Relat Res; 1986 Jun; (207):164-73. PubMed ID: 2424660
[TBL] [Abstract][Full Text] [Related]
40. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
